Advanced search
Publication Cover
Virulence Volume 11, 2020 - Issue 1
Submit an article Journal homepage
2,659
Views
4
CrossRef citations to date
0
Altmetric
Research paper

Epidemiological and clinical differences of coronavirus disease 2019 patients with distinct viral exposure history

Yinjie Gaoa Liver Transplantation and Research Center, Department of Liver Cirrhosis Diagnosis and Treatment Centre, Research Centre for Clinical and Translational Medicine, the Fifth Medical Center, Chinese PLA General Hospital and National Clinical Research Center for Infectious Diseases, Beijing, ChinaORCID Iconhttps://orcid.org/0000-0001-6034-1999View further author information
ORCID Icon,
Xuemei Maa Liver Transplantation and Research Center, Department of Liver Cirrhosis Diagnosis and Treatment Centre, Research Centre for Clinical and Translational Medicine, the Fifth Medical Center, Chinese PLA General Hospital and National Clinical Research Center for Infectious Diseases, Beijing, ChinaView further author information
,
Jingfeng Bia Liver Transplantation and Research Center, Department of Liver Cirrhosis Diagnosis and Treatment Centre, Research Centre for Clinical and Translational Medicine, the Fifth Medical Center, Chinese PLA General Hospital and National Clinical Research Center for Infectious Diseases, Beijing, ChinaView further author information
,
Jindong Chua Liver Transplantation and Research Center, Department of Liver Cirrhosis Diagnosis and Treatment Centre, Research Centre for Clinical and Translational Medicine, the Fifth Medical Center, Chinese PLA General Hospital and National Clinical Research Center for Infectious Diseases, Beijing, ChinaView further author information
,
Bo Liua Liver Transplantation and Research Center, Department of Liver Cirrhosis Diagnosis and Treatment Centre, Research Centre for Clinical and Translational Medicine, the Fifth Medical Center, Chinese PLA General Hospital and National Clinical Research Center for Infectious Diseases, Beijing, ChinaView further author information
,
Chunsheng Chia Liver Transplantation and Research Center, Department of Liver Cirrhosis Diagnosis and Treatment Centre, Research Centre for Clinical and Translational Medicine, the Fifth Medical Center, Chinese PLA General Hospital and National Clinical Research Center for Infectious Diseases, Beijing, ChinaView further author information
,
Jianguo Yana Liver Transplantation and Research Center, Department of Liver Cirrhosis Diagnosis and Treatment Centre, Research Centre for Clinical and Translational Medicine, the Fifth Medical Center, Chinese PLA General Hospital and National Clinical Research Center for Infectious Diseases, Beijing, ChinaView further author information
,
Xiaoli Yua Liver Transplantation and Research Center, Department of Liver Cirrhosis Diagnosis and Treatment Centre, Research Centre for Clinical and Translational Medicine, the Fifth Medical Center, Chinese PLA General Hospital and National Clinical Research Center for Infectious Diseases, Beijing, ChinaView further author information
,
Fangming Liub State Key Laboratory of Medical Molecular Biology, Department of Physiology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaView further author information
,
Xiaohong Dengc Beijing Menlobiotech, Beijing, ChinaView further author information
,
Hongbing Zhangb State Key Laboratory of Medical Molecular Biology, Department of Physiology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaCorrespondence[email protected] [email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0001-6291-1027View further author information
ORCID Icon &
Bo Jina Liver Transplantation and Research Center, Department of Liver Cirrhosis Diagnosis and Treatment Centre, Research Centre for Clinical and Translational Medicine, the Fifth Medical Center, Chinese PLA General Hospital and National Clinical Research Center for Infectious Diseases, Beijing, ChinaORCID Iconhttps://orcid.org/0000-0003-1868-3332View further author information
ORCID Icon show all
Pages 1015-1023 | Received 10 May 2020, Accepted 19 Jul 2020, Published online: 12 Aug 2020

References

  • Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020 Feb 20;382(8):727–733. PubMed PMID: 31978945. Epub 2020/01/25.
  • Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497–506. PubMed PMID: 31986264. Epub 2020/01/28.
  • Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020 Feb 22;395(10224):565–574. PubMed PMID: 32007145. Epub 2020/02/03.
  • International committee on taxonomy of viruses: international committee on taxonomy of viruses. Available from: https://talk.ictvonline.org/
  • World Health Organization. Coronavirus disease (COVID-19) outbreak. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019
  • World Health Organization. Coronavirus disease 2019 (COVID-19) situation Report – 178. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200716-covid-19-sitrep-178.pdf?sfvrsn=28ee165b_2
  • Chinese Center for Disease Control and Prevention. Update on the new coronavirus pneumonia outbreak. Available from: http://www.chinacdc.cn/jkzt/crb/zl/szkb_11803/jszl_11809/202005/t20200501_216522.html
  • Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Feb 15;395(10223):507–513. PubMed PMID: 32007143. Epub 2020/02/03.
  • World Health Organization. Coronavirus disease (COVID-19) technical guidance: laboratory testing for 2019-nCoV in humans. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance
  • Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020 Mar 26;368:m1091. PubMed PMID: 32217556. Epub 2020/03/29.
  • Guidance for corona virus disease 2019: prevention, control, diagnosis and management. People’s Medical Publishing House; 2020.
  • Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020 Feb 28;382:1708–1720. PubMed PMID: 32109013. Epub 2020/02/29.
  • Wang Y, Lu X, Chen H, et al. Clinical course and outcomes of 344 intensive care patients with COVID-19. Am J Respir Crit Care Med. 2020 Apr 8;201:1430–1434. PubMed PMID: 32267160. Epub 2020/04/09.
  • Mizumoto K, Chowell G. Estimating risk for death from 2019 novel coronavirus disease, China, January-February 2020. Emerg Infect Dis. 2020 Mar 13;26(6):1251–1256. PubMed PMID: 32168464. Epub 2020/ 03/14.
  • Wang Y, Zhang D, Du G, et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020;395:1569–1578.
  • Wiersinga WJ, Rhodes A, Cheng AC, et al. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020 Jul 10. DOI:https://doi.org/10.1001/jama.2020.12839. PubMed PMID: 32648899. Epub 2020/ 07/11.
  • Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020 Feb 19;368:m606. PubMed PMID: 32075786. Epub 2020/ 02/23.
  • Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019 Mar;17(3):181–192. PubMed PMID: 30531947. Pubmed Central PMCID: PMC7097006. Epub 2018/ 12/12.
  • Chen J. Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses. Microbes Infect. 2020 Mar;22(2):69–71. PubMed PMID: 32032682. Pubmed Central PMCID: PMC7102641. Epub 2020/02/08.
  • Phan T. Genetic diversity and evolution of SARS-CoV-2. Infect Genet Evol. 2020 Feb 21;81:104260. PubMed PMID: 32092483. Epub 2020/02/25.
  • Forster P, Forster L, Renfrew C, et al. Phylogenetic network analysis of SARS-CoV-2 genomes. Proc Natl Acad Sci U S A. 2020 Apr 8;117(17):9241-9243. PubMed PMID: 32269081. Epub 2020/04/10.
  • Lauer SA, Grantz KH, Bi Q, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020 Mar 10;172:577–582. PubMed PMID: 32150748. Pubmed Central PMCID: PMC7081172. Epub 2020/ 03/10.
  • Li R, Pei S, Chen B, et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2). Science. 2020 Mar 16;368:489–493. PubMed PMID: 32179701. Pubmed Central PMCID: PMC7164387. Epub 2020/ 03/18.
  • Arons MM, Hatfield KM, Reddy SC, et al. Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility. N Engl J Med. 2020 Apr 24;382:2081–2090. PubMed PMID: 32329971. Epub 2020/04/25.
  • Guo YR, Cao QD, Hong ZS, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020 Mar 13;7(1):11. PubMed PMID: 32169119. Epub 2020/03/15.
  • Yin Y, Wunderink RG. MERS, SARS and other coronaviruses as causes of pneumonia. Respirology. 2018 Feb;23(2):130–137. PubMed PMID: 29052924. Epub 2017/ 10/21.
  • Tan L, Wang Q, Zhang D, et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct Target Ther. 2020;5:33. PubMed PMID: 32226636. Pubmed Central PMCID: PMC7100419. Epub 2020/ 04/01.
  • Holshue ML, DeBolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020 Mar 5;382(10):929–936. PubMed PMID: 32004427. Epub 2020/02/01.
  • Grein J, Ohmagari N, Shin D, et al. Compassionate use of remdesivir for patients with severe Covid-19. N Engl J Med. 2020 Apr 10;382:2327–2336. PubMed PMID: 32275812. Epub 2020/ 04/11.
  • Goldman JD, Lye DCB, Hui DS, et al. Remdesivir for 5 or 10 days in patients with severe Covid-19. N Engl J Med. 2020 May 27. DOI:https://doi.org/10.1056/NEJMoa2015301. PubMed PMID: 32459919. Epub 2020/05/28.
  • Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of Covid-19 - preliminary report. N Engl J Med. 2020 May 22. DOI:https://doi.org/10.1056/NEJMoa2007764. PubMed PMID: 32445440. Pubmed Central PMCID: PMC7262788. Epub 2020/05/24.
  • Ledford H. Coronavirus breakthrough: dexamethasone is first drug shown to save lives. Nature. 2020;582:469.
  • Williamson BN, Feldmann F, Schwarz B, et al. Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2. Nature. 2020 Jun 9. DOI:https://doi.org/10.1038/s41586-020-2423-5. PubMed PMID: 32516797. Epub 2020/06/10.
  • Cheng VC, Wong SC, Chuang VW, et al. The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2. J Infect. 2020 Apr 23;81:107–114. PubMed PMID: 32335167. Pubmed Central PMCID: PMC7177146. Epub 2020/ 04/27.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.